Congratulations to the NNHF Project of the Year 2026 Winner
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) shared a post on LinkedIn:
”Congratulations to the NNHF Project of the Year 2026 Winner!
The Novo Nordisk Haemophilia & Haemoglobinopathies Foundation (NNHF) is proud to recognise our Project of the Year 2026: the second East Africa coalition project, a coordinated effort across Kenya, Rwanda, Tanzania, and Uganda.
This project brings four countries together around a shared goal: expanding access to care for people living with haemophilia and sickle cell disease (SCD) and shows what’s possible when partners work as one. The award was handed to the project team by NNHF Council Members Prof Johnny Mahlangu and Prof Saliou Diop.
Here are some of the key achievements:
- 538 new people with haemophilia diagnosed in two years, boosting diagnosis rates by an average of 25%
- 28 clinics established or strengthened, including 13 clinics offering integrated haemophilia and SCD care
- Up to a 10-hour reduction in travel time to receive care
- Partnerships are building sustainable training systems by embedding haemophilia and SCD into medical education pathways in Kenya, Tanzania, and Uganda
Advocacy progress includes:
- Uganda’s Ministry of Health budget commitment for essential treatments and reagents
- Kenya’s parliamentary motion supporting increased government focus and funding (including support through national scheme expansion for SCD)
- Rwanda’s development of treatment guidelines and a national patient registry
Read the full article here.
The East Africa project has now entered a third phase to strengthen SCD and haemophilia infrastructure, in-country training, improved diagnosis, and ongoing advocacy.
Congratulations to all partners and stakeholders involved in the East Africa project!”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026